Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 15,102 | 13,771 | 12,685 | 13,797 | 13,008 | 11,192 | 14,765 | 16,472 | 20,408 | 19,406 | | 18,988 |
% Growth | NA | -8.8% | -7.9% | 8.8% | -5.7% | -14.0% | 31.9% | 11.6% | 23.9% | -4.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | (14,584) | (13,849) | (12,053) | (13,261) | (13,431) | (10,836) | (14,061) | (15,758) | (18,955) | (17,903) | | (17,502) |
Gross Profit | 518 | (78) | 632 | 535 | (423) | 356 | 704 | 714 | 1,453 | 1,503 | | 1,486 |
% Revenue | 3.4% | -0.6% | 5.0% | 3.9% | -3.2% | 3.2% | 4.8% | 4.3% | 7.1% | 7.7% | | 7.8% |
| | | | | | | | | | | | |
Research and Development | (28) | (27) | (22) | (17) | (25) | (49) | (63) | (73) | (129) | (158) | | (163) |
Selling and Marketing | (115) | (109) | (87) | (88) | (86) | (53) | (13) | (19) | (31) | (27) | | (24) |
General and Admin | (214) | (202) | (189) | (171) | (249) | (123) | (138) | (151) | (326) | (382) | | (329) |
Other Inc / (Exp) | 102 | 17 | (104) | 1 | (802) | 53 | (51) | (7) | (196) | (98) | | (132) |
Total Operating Exp | (256) | (320) | (402) | (275) | (1,161) | (172) | (264) | (249) | (682) | (665) | | (649) |
| | | | | | | | | | | | |
Operating Income | 263 | (399) | 230 | 261 | (1,584) | 184 | 440 | 465 | 770 | 838 | | 837 |
% Revenue | 1.7% | -2.9% | 1.8% | 1.9% | -12.2% | 1.6% | 3.0% | 2.8% | 3.8% | 4.3% | | 4.4% |
| | | | | | | | | | | | |
Interest Expense | (204) | (204) | (199) | (192) | (38) | (54) | (149) | (132) | (131) | (81) | | (19) |
Pre-tax Income | 59 | (602) | 30 | 69 | (1,622) | 130 | 291 | 332 | 639 | 757 | | 818 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (19) | (2) | (10) | (10) | (10) | (35) | (82) | (91) | (98) | (122) | | (126) |
Net Income to Company | 40 | (605) | 21 | 58 | (1,632) | 95 | 209 | 241 | 541 | 635 | | 692 |
% Margin | 0.3% | -4.4% | 0.2% | 0.4% | -12.5% | 0.8% | 1.4% | 1.5% | 2.7% | 3.3% | | 3.6% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | (0) | (0) | (3) | 0 | (17) | (50) | (77) | (48) | (23) | | (30) |
Net Income to Stockholders | 40 | (605) | 21 | 55 | (1,632) | 77 | 159 | 164 | 493 | 611 | | 662 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 40 | (605) | 21 | 55 | (1,632) | 77 | 159 | 164 | 493 | 611 | | 662 |
% Margin | 0.3% | -4.4% | 0.2% | 0.4% | -12.5% | 0.7% | 1.1% | 1.0% | 2.4% | 3.1% | | 3.5% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.08 | (1.15) | 0.04 | 0.11 | (3.09) | 0.15 | 0.30 | 0.31 | 0.49 | 0.54 | | 0.54 |
Diluted EPS (Continuing Ops) | 0.08 | (1.15) | 0.04 | 0.11 | (3.09) | 0.15 | 0.30 | 0.31 | 0.49 | 0.54 | | 0.54 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 497.66 | 525.76 | 527.46 | 504.09 | 528.10 | 527.46 | 527.46 | 527.46 | 1,005.97 | 1,131.77 | | 1,235.26 |
WA Diluted Shares Out. | 497.66 | 525.76 | 527.46 | 504.09 | 528.10 | 527.46 | 527.46 | 527.46 | 1,005.97 | 1,131.77 | | 1,235.26 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 59 | (602) | 30 | 69 | (1,622) | 130 | 291 | 332 | 639 | 757 | | 818 |
Addback: Net Interest Expense | 204 | 204 | 199 | 192 | 38 | 54 | 149 | 132 | 131 | 81 | | 19 |
Addback: Other Non Operating Expenses, Total | 26 | 33 | (32) | (9) | 30 | (1) | (4) | (1) | 33 | 23 | | 27 |
Addback: Depreciation & Amortization | 258 | 261 | 273 | 259 | 196 | 83 | 175 | 154 | 282 | 265 | | 252 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 2 | (0) | 125 | 53 | 7 | (0) | 90 | 31 | 81 | 17 | | 1 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 2 | (0) | 0 | (41) | (0) | (13) | (5) | | (8) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 1,368 | 2 | 0 | 1 | 24 | 1 | | 36 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (131) | (66) | 0 | (76) | (631) | (48) | (25) | (54) | (32) | (47) | | (47) |
Adjusted EBITDA | 418 | (171) | 597 | 492 | (614) | 221 | 635 | 596 | 1,144 | 1,092 | | 1,098 |
% Margin | 2.8% | -1.2% | 4.7% | 3.6% | -4.7% | 2.0% | 4.3% | 3.6% | 5.6% | 5.6% | | 5.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 160 | (432) | 324 | 232 | (810) | 137 | 460 | 442 | 863 | 827 | | 846 |
% Margin | 1.1% | -3.1% | 2.6% | 1.7% | -6.2% | 1.2% | 3.1% | 2.7% | 4.2% | 4.3% | | 4.5% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 40 | (605) | 21 | 58 | (1,632) | 95 | 209 | 241 | 541 | 635 | | 692 |
Addback: Unusual Items | (129) | (67) | 126 | (20) | 744 | (46) | 24 | (22) | 59 | (34) | | (18) |
Less: Tax Benefit of Unusual Items (26%) | 34 | 17 | (33) | 5 | (193) | 12 | (6) | 6 | (15) | 9 | | 5 |
Adjusted Net Income | (56) | (654) | 114 | 44 | (1,081) | 61 | 226 | 225 | 585 | 609 | | 678 |
% Margin | -0.4% | -4.7% | 0.9% | 0.3% | -8.3% | 0.5% | 1.5% | 1.4% | 2.9% | 3.1% | | 3.6% |